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Background In-stent restenosis is a difficult percutaneous scenario if calcific neoatherosclerosis is the underlying aetiology.
...................................................................................................................................................................................................
Case summary A 69-year-old diabetic woman with a previous percutaneous coronary intervention on the left anterior descending
coronary artery was readmitted for non-ST-elevation myocardial infarction. In-stent restenosis due to calcific neoa-
therosclerosis was observed by intracoronary imaging during the intervention. Intravascular lithotripsy was used
successfully to fracture the underlying calcific plaque. However, the balloon ruptured during treatment although
this did not damage the artery.
...................................................................................................................................................................................................
Discussion Intravascular lithotripsy is a promising tool for the treatment of extremely calcified lesions including calcific neoa-
therosclerosis of in-stent restenosis. Balloon rupture is a complication of this new percutaneous treatment that has
not previously been described.
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Introduction
Coronary calcification is a strong predictor of major adverse cardiac
events after percutaneous coronary intervention (PCI) because it
complicates device delivery, expansion, and apposition, predisposing
to stent failure.1 Intracoronary lithotripsy is a new tool for treatment
of extremely calcified coronary lesions by fracturing the calcified pla-
que, thus allowing mean area gain and facilitating stent apposition and
expansion.2,3 However, balloon rupture may occur during treatment.
Prompt detection of this complication is needed so that rapid meas-
ures can be taken to avoid damage to the vessel.
Learning points
• In-stent restenosis by underlying calcific neoatherosclerosis is a
challenging percutaneous scenario.
• Rotational atherectomy may be performed with caution due
to risk of burr stuck if associated under-expansion of the stent
is present.
• Intracoronary lithotripsy may be included into the tools to
treat extremely calcified lesions.
• Intracoronary imaging should be performed to understand the
aetiology of the in-stent restenosis and guide the treatment.
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The patient was a 69-year-old woman, with diabetes mellitus, obesity,
and asthma. In 2003, she had a non-ST-elevation myocardial infarc-
tion (NSTEMI) that was treated with a PCI at the proximal and
mid-left anterior descending coronary artery (LAD) stent at another
facility. In 2016, she was readmitted for a new NSTEMI. Coronary
angiography showed a 45% in-stent restenosis and an 85% lesion at a
marginal branch, which was treated with 2.75 mm 26 mm drug-
eluting stent (DES). She did not attend post-hospitalization and was
lost to follow-up. In January 2019, she was again readmitted for
NSTEMI Killip Class III.
On physical examination, the patient was found to have hyperten-
sion (non-invasive arterial pressure was 147/75 mmHg), tachycardia
(96 b.p.m.), a basal oxygen saturation of 94%, bilateral basal crackles,
no cardiac murmurs, and absence of limb oedema. Echocardiography
was not performed due to a poor acoustic window.
Coronary angiography showed a moderate restenosis of the LAD
stent with no other significant lesion (Figure 1A and Supplementary
material online, Video S1). During the diagnostic catheterization, inva-
sive left ventricular (LV) end-diastolic pressure was measured reveal-
ing high LV filling pressure (20 mmHg). An invasive haemodynamic
evaluation with resting full-cycle ratio (RFR) was performed, finding a
significant LAD ischaemia (RFR 0.75) with a clear step-up into mid-
and proximal LAD. Two wires were inserted: one into the LAD and
a second wire to protect the first diagonal branch. In contrast to
other plaque modification devices, intravascular lithotripsy may be
used safely with several wires left in place. Attempts to expand the
proximal part of the LAD stent and the proximal LAD were unsuc-
cessful using a progressive 3.0 high-pressure cutting balloon and a 3.5
non-compliant high-pressure balloon. Intravascular ultrasound
(IVUS) showed there was neoatherosclerosis with a 360 calcific
arch at the proximal part of the LAD stent and at the proximal LAD;
there was no fracture on the calcific arch or dissection at the prox-
imal LAD (Supplementary material online, Video S2). The proximal
reference vessel size was 3.5 mm 3.6 mm (Figure 1B).
Intravascular lithotripsy was planned in order to treat the calcified
neoatherosclerosis and prevent sudden closure of the first diagonal
branch. Initially, lithotripsy with a 3.0 12 balloon at the mid-distal
part of the stent was performed. As a good expansion was achieved
with two cycles of pulses, the balloon was then retrieved to the cen-
tral and proximal part of the stent. However, the balloon ruptured at
the third cycle of pulses (Supplementary material online, Video S3), al-
though it had been applied at the recommended pressure (4 atm).
The emission of pulses was immediately stopped (Figure 1C) with dis-
tal downstream embolization of balloon contents. Transient ST-
elevation on electrocardiogram and a drop in the blood pressure
were observed and resolved with retrieval of the balloon and applica-
tion of intracoronary nitroprusside. A coronary angiography showed
that there was no distal dissection or vessel rupture (Supplementary
material online, Video S4). Then, another 3.5 12 lithotripsy balloon
at proximal LAD was used to treat the proximal in-stent and prox-
imal LAD (Figure 2A). Following lithotripsy, an IVUS showed multiple
fractures of the 360 calcific neoatherosclerosis plaque (Figure 2B,
white arrows and Supplementary material online, Video S5). Then, a
3.5 mm 22 mm DES was implanted covering the proximal previous
stent to the LAD ostium, expansion was good, and the final result
was excellent (Figure 2C and Supplementary material online, Video S6).
The patient is on double antiplatelet therapy (with a recom-
mended duration of at least 12 months) and is still uneventful
12 months after the intervention.
Discussion
In-stent restenosis due to calcific neoatherosclerosis is a challenging
scenario in which different PCIs such as rotational and orbital athe-
rectomy, intravascular lithotripsy, and intracoronary laser have been
tested.4–6 The aim of all of these techniques is to adequately modify
the calcific plaque in order to obtain a sufficient minimal lumen area
and an expandable intima. Intravascular lithotripsy enables to treat
calcific lesions in arteries larger than 2.5 mm without dislodgement of
debulked material, through a semi-compliant balloon. However, if
the lesion is extremely severe or there is tortuosity at the proximal
part of the artery, the lithotripsy balloon may not advance into the le-
sion. In this case, a mother-in-child catheter may help to advance the
balloon into the lesion7 but if this technique is not successful, an alter-
native therapy (rotational atherectomy) may be used.
So far, few complications had been reported from patients treated
with this new technology.2–9 However, here we report the rupture
of the balloon in the treatment of an in-stent restenosis lesion at the
third cycle of pulses. Balloon laceration may be induced by fractured
calcium from the atherosclerotic plaque, leading to balloon rupturing
during the treatment. Intracoronary lithotripsy emitters stop as soon
as there is no fluid inside the balloon; and then the propagation of the
pressure waves decreases and finally stops. Therefore, continuous
fluoroscopy is advisable for early detection of balloon leakage in
.................................................................................................
69-Year-old obese, diabetic, and asthmatic woman
2003 Non-ST-elevation myocardial infarction (NSTEMI) Killip
Class I: coronary angiography showed one vessel disease
treated with left anterior descending coronary artery
(LAD) stenting
2016 NSTEMI Killip Class I: coronary angiography showed non-
significant in-stent restenosis and severe lesion at a mar-
ginal branch of left circumflex treated with drug-eluting
stent
2019 NSTEMI Killip Class III: coronary angiography showed dif-
fuse in-stent LAD restenosis with positive haemodynam-
ic invasive testing. Intracoronary imaging with
intravascular ultrasound revealed severe calcified neoa-
therosclerosis. Plaque modification with intracoronary
lithotripsy was performed. Balloon rupture occurred
during treatment and distal embolization resolved with
the retrieval of the balloon and intracoronary nitro-
prussiate administration
2020 Uneventful at 12 months of follow-up
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Figure 1 Left coronary angiography (A) showing a diffuse in-stent restenosis involving proximal and mid-left anterior descending coronary artery.
Initial treatment with a 3.0 mm cutting balloon and 3.5 mm non-compliant balloon that did not reach adequate expansion (B). Intravascular ultrasound
performed after unsuccessful attempts to dilate left anterior descending coronary artery showed a 360-calcific neoatherosclerosis involving the
mid- and proximal part of the stent with a minimal diameter of 2 mm (C).
Figure 2 Initial inflation of the lithotripsy balloon at the mid-stent left anterior descending coronary artery and rupture at 25 pulses with dye leak-
age in distal left anterior descending coronary artery (A). Adequate expansion of the 3.5 mm 12 mm lithotripsy balloon at the proximal part of the
left anterior descending coronary artery stent. Angiography and intravascular ultrasound performed after the lithoplasty showing calcium rupture
and absence of vessel perforation or distal dissection (B). Final result after implantation of a 3.5 mm 22 mm drug-eluting stent (C).






















































..order to rapidly stop the emission of pulses and protect the vessel
from further damage.
Conclusion
Intracoronary lithotripsy is a new technology that is becoming an es-
sential tool to treat extremely calcified coronary lesions. However,
this procedure must still prove clinical benefits and safety in large ser-
ies with different types of calcific lesions. The larger series of studies
are needed in order to confirm the good results of small series of
cases and to assess the rate of complications, such as the balloon rup-
ture reported in this case study.
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